Studies on the mechanism of integrin inside-out activation have been focused on the role of b-integrin cytoplasmic tails, which are relatively conserved and bear binding sites for the intracellular activators including talin and kindlin. Cytoplasmic tails for a-integrins share a conserved GFFKR motif at the membrane-proximal region and this forms a specific interface with the b-integrin membraneproximal region to keep the integrin inactive. The a-integrin membrane-distal regions, after the GFFKR motif, are diverse both in length and sequence and their roles in integrin activation have not been well-defined. In this study, we report that the a-integrin cytoplasmic membrane-distal region contributes to maintaining integrin in the resting state and to integrin inside-out activation.
INTRODUCTION
Integrins are cell surface molecules composed of a and b subunits, each containing a large extracellular domain, a short transmembrane (TM) domain, and usually a short cytoplasmic tail (CT). The combination of 18 a-integrin and eight b-integrin subunits results in 24 human integrins, and these play important roles in diverse biological processes including cell migration, morphogenesis, hemostasis and the immune response (Hynes, 2002) . Integrins transmit signals between their extracellular ligands and the intracellular cytoskeleton through bidirectional signaling across cell membrane (Kim et al., 2011b; Springer and Dustin, 2012) . Intracellular stimulations impinging on the integrin CT induce conformational changes that transform resting integrin into a high-affinity ligand-binding-competent state (known as integrin activation or inside-out signaling). Ligand binding to the extracellular domain induces integrin conformational rearrangement and transmits signals to the cytoplasmic side (known as integrin outside-in signaling). The integrin TM and CT domains play pivotal roles in the bidirectional signaling process.
The large-scale integrin conformational rearrangements, including the changing from a bent to an extended, and from a closed to an open headpiece conformation, have been directly visualized by electron microscopy (EM) (Takagi et al., 2002; Nishida et al., 2006; Ye et al., 2010; Eng et al., 2011; Zhu et al., 2012) , crystallography (Xiao et al., 2004; Zhu et al., 2013) , and small angle X-ray scattering (Mould et al., 2003; Eng et al., 2011) . Integrin conformational change was also demonstrated on the cell surface by the exposure of epitopes (known as ligand-induced-binding sites, LIBS) that are masked in the inactive state (Frelinger et al., 1991; Sims et al., 1991; Humphries, 2004; Byron et al., 2009) . It has been demonstrated that both integrin extension and headpiece opening are required for high-affinity ligand binding (Chen et al., 2010; Springer and Dustin, 2012) , which is crucial for platelet aggregation mediated by integrin a IIb b 3 at the bleeding sites and neutrophil arrest mediated by integrin a L b 2 at the inflamed tissues (Lefort et al., 2012) .
Integrin inside-out activation is regulated through the CT. Sequence alignment shows that b-integrin CTs are relatively conserved at both the membrane-proximal (MP) and membranedistal (MD) regions, which have common binding sites for regulatory proteins like talin and kindlin (supplementary material Fig. S1 ) (Anthis and Campbell, 2011; Kim et al., 2011b; Margadant et al., 2011; Morse et al., 2014) . In contrast, a-integrin CTs are only highly conserved at the MP regions, which have a Gly-PhePhe-Lys-Arg (GFFKR) motif, whereas the MD regions vary substantially both in sequence and length (supplementary material Fig. S1 ). It is known that the a-integrin CT MP region is required for keeping the integrin inactive (O'Toole et al., 1991; O'Toole et al., 1994; Hughes et al., 1995; Hughes et al., 1996; Lu and Springer, 1997; Zhu et al., 2009 ), but the role of a-integrin CT MD region in integrin activation is not well characterized.
Mutational studies have suggested that the specific associations of a-integrin and b-integrin TM and CT domains maintain integrin in the resting state (O'Toole et al., 1994; Hughes et al., 1995; Luo et al., 2005; Partridge et al., 2005; Berger et al., 2010) . This was confirmed by the structural studies of the a IIb b 3 TM and CT domains performed by the disulfide crosslinking assay using intact integrin on the cell surface (Zhu et al., 2009) (Fig. 1A) and by NMR using the isolated peptides either in lipid bicelles (Fig. 1B ) or in organic solvent (Yang et al., 2009) (Fig. 1C) . The three structures share a similar interface at the TM domain, but differ at the CT (Fig. 1A-C) . Although the disulfidebased and the NMR structure in lipid bicelles have a similar conformation at the CT MP regions (Fig. 1A,B) , there are different interpretations of how the conserved residues, such as b 3 -K716, contribute to integrin activation (Zhu et al., 2009; Kim et al., 2011a; Kurtz et al., 2012) . The NMR structure in organic solvent has a very different conformation at the MP region as compared with the other structures (Fig. 1C) . It is not known whether such structural diversity is due to the different environments used for structure determination or whether it represents a dynamic conformational change. The structure of a IIb CT MD region is not well-defined and varies among all the structures (Fig. 1A-C) . It is not known whether this region contributes to maintaining the resting integrin conformation.
In the inside-out integrin activation, the cytosolic protein talin (which has two isoforms, talin-1 and -2) binds to both the MD and MP regions of the b-integrin CT through its head domain, which is composed of F0, F1, F2 and F3 subdomains, resulting in conformational changes in the integrin TM and CT domains, which are propagated to the extracellular domains across cell membrane (Kim et al., 2011b) . Kindlin (which has three isoforms, kindlin-1, -2 and -3) has been found to cooperate with talin during integrin activation through direct binding to the b-integrin CT MD region (Ma et al., 2008; Moser et al., 2008; Harburger et al., 2009; Malinin et al., 2009; Moser et al., 2009b; Svensson et al., 2009; Bledzka et al., 2012) . Studies on how talin changes integrin conformation have been focused on the b-integrin TM and CT domains, and have been described in many elegant reviews (Moser et al., 2009a; Shattil et al., 2010; Anthis and Campbell, 2011; Kim et al., 2011b; Calderwood et al., 2013; Das et al., 2014) . Recent structural and functional studies suggest that talin-1 binding to the b 3 CT changes the tilt angle of b 3 TM domain in the cell membrane, thus disturbing the a-integrin-b-integrin interfaces at the TM and MP regions (Kalli et al., 2011; Kim et al., 2011a; Kim et al., 2012) . A crystal structure of the talin-2 F2-F3 domain bound to b 1D -CT suggests that there is an ionic interaction between a lysine residue in the talin-2 F3 domain and the conserved aspartic acid residue of the b 1D integrin CT MP region (Anthis et al., 2009 ). This interaction was proposed to be important in integrin activation by disrupting the putative saltbridge (between a IIb -R995 and b 3 -D723) at the a-integrin-b- 
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D E V 9 9 0 T r G 9 9 1 T r F 9 9 2 T r F 9 9 3 T r K 9 9 4 T r R 9 9 5 T r N 9 9 6 T r R 9 9 7 T r P 9 9 8 T r P 9 9 9 T r L integrin MP interface that has been suggested to maintain the resting integrin state (Hughes et al., 1996) . However, it is not known if or how the a-integrin CT, and especially the MD region, participates in talin-and kindlin-induced integrin activation. In this study, we examined the role of a IIb , a V and a L integrin CT MD regions in the regulation of integrin activation. We report that the a-integrin CT MD region helps maintain integrin in the resting state and is indispensable in talin-and kindlin-induced integrin conformational change and ligand binding. The proper length and proper amino acids are important for the a-integrin CT MD region to exert its effect on integrin activation. During the preparation of our manuscript, Li et al. (Li et al., 2014) reported that the a IIb CT MD region is required for a IIb b 3 inside-out activation and proposed a model of 'steric clashes' between the talin-1 head and the a IIb CT MD region that is involved in integrin activation. Our data of a IIb b 3 are consistent with their results, but our comprehensive analysis on multiple integrins suggests a more complicated mechanism by which the a-integrin CT MD region regulates integrin activation.
RESULTS
The CT MP region is the minimum structural requirement for maintaining a IIb b 3 integrin in the resting state
To determine the minimum structure requirement of a IIb b 3 CT for maintaining the resting state, we performed a serial truncation mutagenesis. a IIb CT truncations before F993 greatly reduced integrin cell surface expression, whereas other truncations had a minor effect (supplementary material Fig. S2A ). Similarly, b 3 CT truncations before but not after I719 greatly reduced integrin expression (supplementary material Fig. S2B ). The ligandmimetic monoclonal antibody (mAb) PAC-1 was used to assess a IIb b 3 activation. PAC-1 binding to all the a IIb CT truncations after R995 was comparable to that for wild-type (WT) integrin (Fig. 1D ). Truncation after a IIb -K994 only slightly increased PAC-1 binding, whereas truncations after a IIb V990, G991, F992 and F993 greatly enhanced PAC-1 binding (Fig. 1D , truncations are denoted by the suffix Tr). For b 3 integrin, there was no detectable activation for all the b 3 CT truncations after I721 (Fig. 1E) . b 3 -W715Tr, b 3 -K716Tr and b 3 -L717Tr strongly induced PAC-1 binding, and truncation after b 3 -L719 weakly induced PAC-1 binding (Fig. 1E) Truncations after the a IIb CT MP region might decrease the threshold for integrin activation because of structure incompleteness. To test this possibility, we performed a PAC-1 binding assay for the a IIb CT truncations co-expressed with the constitutively active b 3 mutants, b 3 -G708L or b 3 -K716A. These b 3 mutations have been known to activate a IIb b 3 by disturbing the TM interaction (Luo et al., 2005; Zhu et al., 2009; Kim et al., 2011a) . Compared with WT a IIb , truncation after a IIb -F993, K994, R995, N996, R997 or P998 strongly enhanced PAC-1 binding to both b 3 -G708L and b 3 -K716A mutants ( Fig. 2A,B) . This is in contrast with the very subtle or undetectable activating effect of these a IIb truncations when paired with WT b 3 (Fig. 1D) . The truncation-amplified activating effect was decreased with the increase of the length of a IIb CT MD region ( Fig. 2A,B) . More strikingly, the b 3 -G708A mutation very weakly induced PAC-1 binding when paired with WT a IIb , but its activating effect was greatly enhanced upon deletion of the a IIb CT MD region (Fig. 2C ). In addition, the enhanced activating effect of a IIb CT MD deletion on the b 3 -G708L mutation was close to the maximal level, given that Mn 2+ did not further increase PAC-1 binding (Fig. 2C) . Similar results were obtained with the active b 3 -G135A mutant, which facilitates formation of the active conformation of b 3 -I domain (Zhang et al., 2013) . Complete deletion of the a IIb CT MD region enhanced the activation of b 3 -G135A (data not shown). These data demonstrate that deletion of the a IIb CT MD region renders the integrin hyper-reactive to b 3 -activating mutations. Therefore, the a IIb CT MD region contributes to maintaining integrin in the resting state.
Deletion of the a IIb CT MD region abolishes the activating effect of a IIb -R995 and b 3 -D723 mutations
Integrin activation induced by the a IIb -R995 and b 3 -D723 mutations has been shown to depend on talin-1 binding to the b 3 CT, which is distinct from the activation mechanism promoted by the activating mutations at the TM domain (Wegener et al., 2007) . We asked whether the a IIb CT MD truncations exert different effects on a IIb -R995 and b 3 -D723 mutations. The b 3 -D723R mutant constitutively bound PAC-1 when paired with a IIb WT (Fig. 2D) . However, PAC-1 binding was reverted to a WT level when b 3 -D723R was paired with the a IIb truncations F993Tr, K994Tr, R995Tr or N996Tr, in which all or most of the MD region is deleted (Fig. 2D) . Strikingly, although both a IIbF993Tr and b 3 -D723R were constitutively active when paired with their WT partners, their combination abolished the activating effect (Fig. 2D ). This is in sharp contrast with the amplified activation mediated by the a IIb truncations for the b 3 -G708L and b 3 -K716A mutants ( Fig. 2A,B) . Retaining two or more residues of the a IIb MD region restored or increased integrin activation induced by the b 3 -D723R mutation (Fig. 2D) .
We further verified our results with the a IIb -R995A and a IIb -R995D mutation. Both of these mutations render a IIb b 3 active to bind PAC-1 in the context of full-length a IIb (Fig. 2E) . Their activating effects were abolished when the a IIb CT MD region was completely deleted (Fig. 2E) . By contrast, the activation by a IIb -F992A or a IIb -F993A mutation was enhanced upon the a IIb CT MD deletion (Fig. 2E ). These data suggest that the a IIb CT MD region plays a positive role in integrin inside-out activation.
The a-integrin CT MD region is required for talin-1-induced integrin activation
The deactivating effect of a IIb CT MD truncation on a IIb -R995 and b 3 -D723 mutations raises the intriguing possibility that the a IIb CT MD region might participate in talin-mediated integrin activation. We performed a well-established integrin activation assay by overexpressing the EGFP-tagged talin-1 head domain (EGFP-TH) (Bouaouina et al., 2012) . As expected, overexpression of EGFP-TH significantly activated WT a IIb b 3 as determined by the amount of PAC-1 binding (Fig. 3A) . The EGFP-TH-induced activation was much more substantial for integrin bearing a IIb -R995A or b 3 -D723A mutation, indicating a synergetic effect (Fig. 3A) . However, EGFP-TH failed to induce PAC-1 binding to the a IIb -R995Tr mutant, i.e. the a IIb CT MD region was deleted (Fig. 3A) . Remarkably, the strong activating effect of EGFP-TH on a IIb -R995A or b 3 -D723A was also completely lost in the absence of the a IIb CT MD region (Fig. 3A) . The expression levels of EGFP-TH or integrins were comparable among all the transfectants (supplementary material Fig. S2C) . These results clearly demonstrate the requirement of a IIb CT MD region in talin-1-head-induced a IIb b 3 activation.
We next examined whether the CT MD region is also important for talin-induced activation of other a-integrins. We found that overexpression of EGFP-TH significantly enhanced the binding of fibronectin type III domain 9-10 (Fn9-10) and intercellular adhesion molecule 1 (ICAM-1) to a V b 3 and a L b 2 , respectively ( Fig. 3B,C) . In contrast, when the CT MD region was completely deleted for a V or a L integrin (a V -R993Tr or a L -R1094Tr), the talin-1 head failed to augment ligand binding for these integrins (Fig. 3B,C) . The expression levels of EGFP-TH or integrin are comparable among the transfectants (supplementary material Fig. S2D ,E). Thus, the requirement for an a-integrin CT MD region for talin-mediated integrin activation could be a generalized property of integrins.
The a-integrin CT MD region is required for kindlin-induced integrin activation
Having demonstrated the indispensable role of the a-integrin CT MD region in talin-induced integrin activation, we next asked whether the a-integrin CT MD region is also required for kindlinmediated integrin activation. Given that integrin activation by kindlin requires the presence of talin (Ma et al., 2008) , we examined the effect of deletion of the a-integrin CT MD region on kindlin-mediated integrin activation with co-expression of the talin-1 head. Overexpression of mCherry-tagged kindin-2 (mC-K2) significantly enhanced PAC-1 binding to WT a IIb b 3 (Fig. 3D) . We also detected a slight increase of PAC-1 binding induced by mCherry-kindlin-3 (mC-K3), but it was not statistically significant compared with the mCherry control (Fig. 3D ). In the absence of a IIb CT MD region (a IIb -R995Tr), mC-K2-mediated PAC-1 binding was greatly and significantly (P,0.01) reduced compared with the WT (Fig. 3D) . As a control, the talin-1 head and kindlins failed to induce PAC-1 binding to a IIb -b 3 -R724Tr owing to the deletion of the binding sites for talin-1 and kindlin (Fig. 3D) . The expression levels of EGFP-TH, mC-K2 or mC-K3 were comparable among all the transfectants (supplementary material Fig. S3A,B ). These data demonstrate that the a IIb CT MD region is required for kindlin-mediated a IIb b 3 activation.
Similar results were obtained with a V b 3 and a L b 2 integrins. In the presence of the talin-1 head, kindlin-2 but not kindlin-3 α I I b / 3 W T I I b -F 9 9 3 T r / 3 F 9 9 3 T r K 9 9 4 T r R 9 9 5 T r N 9 9 6 T r R 9 9 7 T r P 9 9 8 T r P 9 9 9 T r L markedly enhanced fibronectin (Fn) binding to WT a V b 3 (Fig. 3E ). Both kindlin-2 (P,0.01) and kindlin-3 (P,0.05) significantly increased ICAM-1 binding to WT a L b 2 , but the level of increase by kindlin-3 was significantly (P,0.05) lower than by kindlin-2 (Fig. 3F) . Deletion of the CT MD region of a V (a V -R993Tr) or a L (a L -R1094Tr) significantly (P,0.01) and greatly reduced the kindlin-2-mediated ligand binding (Fig. 3E,F) . The kindlin-3-induced ICAM-1 binding was also greatly reduced for the a LR1094Tr-b 2 mutant (Fig. 3F ). The expression levels of EGFP-TH, kindlin-2 or kindlin-3 were comparable among the transfectants of a V b 3 (supplementary material Fig. S3C,D) and among the transfectants of a L b 2 (supplementary material Fig. S3E,F) . These data strongly demonstrate that the a-integrin CT MD region is also required for kindlin-mediated integrin activation.
The kindlin-2-mediated ligand binding was not completely abolished in the absence of the a-integrin CT MD region. The low level increase of ligand binding upon the overexpression of kindlin-2 was statistically significant for a IIb -R995Tr-b 3 (P,0.05) and a L -R1094Tr-b 2 (P,0.01) (Fig. 3D,F) , but not for a V -R993Tr-b 3 (Fig. 3E ). In addition, we could detect a moderate increase (P50.05) of kindlin-3-mediated ICAM-1 binding to the a L -R1094Tr-b 2 mutant (Fig. 3F) . Given that PAC-1, Fn, and ICAM-1 are all multivalent ligands, the low level of ligand binding was probably due to the integrin clustering effect of kindlin as suggested by a recent study (Ye et al., 2013) .
The a-integrin CT MD region is required for PMA-stimulated integrin activation in K562 cells
We further validated our data by expressing the a IIb b 3 integrin in human K562 cells. PMA was used to stimulate integrin activation, which mimics the physiological integrin inside-out activation cascade (Banno and Ginsberg, 2008) . We did not detect PMAinduced PAC-1 binding to WT a IIb b 3 (data not shown). However, PMA induced PAC-1 binding to a IIb -b 3 -D723A in a concentrationdependent manner (Fig. 4A) , indicating that the b 3 -D723A mutation enhanced integrin sensitivity to PMA stimulation. Consistent with the results obtained upon overexpression of talin-1 head and kindlins, complete deletion of the a IIb CT MD region abolished PMA-induced PAC-1 binding (Fig. 4A,B) .
Retaining two residues of a-integrin CT MD region partially restores talin-1-induced activation of a IIb b 3 , but not a V b 3 and a L b 2 integrins
We next asked how the a-integrin CT MD region participates in talin-mediated integrin activation. Structural superposition of talin bound to the b-CT and the a IIb b 3 TM-CT heterodimer suggests that there can be steric clashes between the talin head and a IIb MD residues that are close to b 3 and immediately follow the GFFKR motif (i.e. residues N996-R997) (supplementary material Fig. S4A,B) . To test whether the potential steric clash plays a role in talin-mediated integrin activation, we made truncated a IIb constructs that had the two native residues, NR997Tr, two small residues, GG997Tr and AA997Tr, or two bulky residues, YY997Tr and WW997Tr, at the MD region (Fig. 5A) . If the steric clashes are important, we would expect to see that the mutations with bulky residues would have a greater activating effect on talin-mediated integrin activation than the mutations with small residues. All the mutants had comparable levels of PAC-1 binding to that shown by WT a IIb when paired with b3 WT, except that the WW997Tr mutant was constitutively active (Fig. 5A ). The talin-1 head augmented PAC-1 binding to all the truncated a IIb mutants co-expressed with WT b 3 (Fig. 5B ). The WW997Tr mutant had a much higher level of PAC-1 binding than other constructs owing to its constitutive activation (Fig. 5B) . We consistently observed that a lower level of PAC-1 binding was induced by the talin-1 head for the YY997Tr mutant than for the other constructs (Fig. 5B) . We then examined the same a IIb mutants in the context of b 3 -D723A mutation, which is expected to enhance the sensitivity of the assay. The talin-1 head induced similar levels of PAC-1 binding to a IIbNR997Tr, a IIb -GG997Tr, and a IIb -AA997Tr mutants coexpressed with b 3 -D723A, but the binding was significantly (P,0.001) lower than for a IIb -WT co-expressed with b 3 -D723A (Fig. 5C ). Strikingly, talin-1-head-induced PAC-1 binding to a IIbYY997Tr mutant was significantly (P,0.01) lower than with a IIb -NR997Tr and the other constructs (Fig. 5C ). When the NR997 was replaced by YY997 in the context of full-length a IIb , the a IIb -YY997 mutation also significantly reduced talin-1-headmediated activation of b 3 -D723A (Fig. 5C ). We next extended the C-termini of a IIb CT with a 29-residue tag of V5 epitope plus hexahistidine, which would be expected to provide more clashes with talin-1 head. We found that the response to talin-1-headinduced activation for V5-His-tagged a IIb was indistinguishable from WT a IIb (data not shown). This result, in accordance with the YY997 mutation data, suggests that it is not plausible to assign a simple 'steric clash' model to the mechanism by which a IIb CT MD region participates in integrin activation. We extended our study to a V b 3 and a L b 2 integrins. Consistent with a IIb b 3 , the presence of b 3 -D723A or the equivalent b 2 -D709A mutation significantly enhanced talin-1-head-induced binding of Fn9-10 and ICAM-1 to a V b 3 and a L b 2 , respectively (Fig. 5D,E) . Complete deletion of the a V and a L CT MD region (aV-R993Tr and aL-R1094Tr) totally abolished the activating effect of the talin-1 head (Fig. 5D,E) . However, retaining two residues in the a V and a L CT MD region (aV-R995Tr and aLR1096Tr) did not restore talin-1-head-induced integrin activation (Fig. 5D,E) . This is in contrast to the result showing that retaining two residues at the a IIb CT MD region partially restores talin-1-induced a IIb b 3 activation. In addition, retaining eight residues for the a L CT MD region (a L -A1102Tr) was still not sufficient to restore talin-1-head-induced integrin activation to the WT a L level (Fig. 5E) . Thus, different a integrins might have different requirements for the CT MD region in talin-1-mediated activation. The suitable amino acids and proper length of aintegrin CT MD region are required for sufficient integrin activation.
The a-integrin CT MD region is required for talin-and kindininduced integrin conformational change It is generally accepted that talin activates integrin through inducing conformational change (Anthis and Campbell, 2011; Kim et al., 2011b) . By using conformation-dependent LIBS mAbs, we examined the talin-1-head-induced conformational change of integrin ectodomains. Consistent with our previous results (Zhang et al., 2013) , overexpression of the talin-1 head significantly increased the binding of the b 3 LIBS mAb 319.4, but not the a IIb LIBS mAb 370.3 to WT a IIb b 3 (Fig. 6A,B) . The b 3 -D723A or a IIb -R995A mutation markedly enhanced the talin-1-head-induced binding of both mAbs to full-length a IIb b 3 (Fig. 6A,B) . However, deletion of a IIb CT MD region significantly reduced talin-1-head-induced mAb binding (Fig. 6A,B) . Similarly, the talin-1 head significantly increased the binding of the b 2 LIBS mAbs KIM127 and M24 to WT a L b 2 , but not to a L -R1094Tr-b 2 (Fig. 6C,D) . The expression levels of talin-1 head were comparable among the transfectants (data not shown). Thus, the a-integrin CT MD region is required for talin-induced integrin conformational change.
We next asked whether the a-integrin CT MD region is also important for kindlin-mediated integrin conformational change. When co-expressed with the talin-1 head, kindlin-2, but not kindlin-3 significantly increased the binding of the mAbs 319.4 and 370.3 to WT a IIb b 3 (Fig. 7A,B) . This is consistent with the data that kindlin-2 but not kindlin-3 enhanced ligand binding to WT a IIb b 3 (Fig. 3D) . Kindlin-2 also significantly enhanced the binding of KIM127 and M24 to WT a L b 2 (Fig. 7C,D) . We also detected kindlin-3-induced binding of M24 to WT a L b 2 (P,0.05) (Fig. 7D) . The binding of KIM127 was also increased by kindlin-3, but it is not statistically significant (Fig. 7C) . By contrast, both kindlin-2 and kindlin-3 failed to induce the binding of mAbs to the truncated a IIb -R995Tr-b 3 and a L -R1094Tr-b 2 integrins (Fig. 7) . The expression levels of the talin-1 head and kindlin-2 or kindlin-3 were comparable among the integrin transfectants (data not shown). These results demonstrate that the a-integrin CT MD region is also required for kindlin-mediated integrin conformational change.
Deletion of the a IIb integrin CT MD region reduced a IIb b 3 transmembrane heterodimerization but did not affect the binding of the talin-1 head
To have direct evidence that the a IIb CT MD region contributes to a IIb b 3 TM association, we performed a disulfide crosslinking assay with integrins on the cell surface. Consistent with our previous data (Zhu et al., 2009) , disulfide bonds were formed at high efficiency between the cysteine mutations of interfacial residues a IIb -G972C and b 3 -V700C at the TM domains (Fig. 8A) , indicating the close TM association of a IIb b 3 (Fig. 1A) . However, the disulfide bond formation was significantly reduced upon the deletion of a IIb CT MD region (Fig. 8A) , suggesting a disassociation of TM domains. As a control, deletion of both the MP and the MD regions of a IIb CT (a IIb -G972C-V990Tr) further reduced disulfide bond formation (Fig. 8A ). This is consistent with the ligand-binding assay. Deletion of the a IIb CT MD region greatly enhanced PAC-1 binding to the a IIb -G972C mutant but not the b 3 -V700C mutant, whereas deletion of the a IIb CT MP region further enhanced PAC-1 binding due to the increased dissociation of a IIb b 3 transmembrane domains (Fig. 8A,B) . This data clearly demonstrate that the a IIb CT MD region contributes to a IIb b 3 transmembrane association, which helps to keep integrin inactive. We next asked whether deletion of the a IIb CT MD affects the binding of talin-1 head to a IIb b 3 integrin. As shown in Fig. 8C , the EGFP-TH was co-immunoprecipitated with both WT a IIb b 3 and a IIb -R995Tr-b3 mutant, suggesting that the loss of talin-mediated integrin activation in the absence of the a IIb CT MD region is not due to the effect on talin-1 head binding.
DISCUSSION
We present evidence to support the previously unappreciated structural roles of the a-integrin CT MD region in integrin activation. In addition to the well-conserved MP region, the aintegrin CT MD region also contributes to maintaining integrin in the resting state. Deletion of the a IIb CT MD region lowers the 
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threshold of mutation-induced integrin activation. This is due to the reduced association of a IIb b 3 TM domains in the absence of the a IIb CT MD region as demonstrated by a disulfide crosslinking assay. Furthermore, we demonstrate that the aintegrin CT MD region is required for talin-and kindlin-induced inside-out activation of a IIb , a V , and a L integrins, which is indicative of an essential and conserved mechanism of integrin activation. The a-integrin CT MD region is dispensable for talin binding but is required for talin-and kindlin-induced integrin conformational change. Our data explain to a certain extent the previous observations that deletion of the a-integrin CT MD region diminished cell adhesion mediated by a 1 , a 2 , a 4 , a V and a 6 integrins (Kassner and Hemler, 1993; Kawaguchi and Hemler, 1993; Shaw and Mercurio, 1993; Filardo and Cheresh, 1994; Kassner et al., 1994; Kawaguchi et al., 1994; Yauch et al., 1997; Abair et al., 2008) and that the a L CT MD deletion reduced the sensitivity of a L b 2 integrin to PMA stimulation (Lu and Springer, 1997) . It is not readily known how the a-integrin CT MD region contributes to maintaining the resting state because current structural studies show diverse structures for the integrin cytoplasmic tails (supplementary material Fig. S4 ). Several models could be proposed according to the data available (supplementary material Fig. S4C ). First, our data demonstrate that in addition to the MP regions, the a IIb MD region contributes to integrin TM association on the cell surface. A recent report has shown that complete deletion of the a IIb CT MD region reduced the interaction of isolated a IIb and b 3 TM-CT peptides co-expressed on the cell surface (Li et al., 2014) . Our disulfide crosslinking experiments (Zhu et al., 2009 ) and a direct interaction assay (Ginsberg et al., 2001 ) indicate a close association of a IIb MD region with b 3 cytoplasmic tail. Thus, the a IIb MD region might contribute to the structural stability of an a IIb b 3 TM-CT heterodimer through a direct interaction with the b 3 cytoplasmic tail. This interaction might be sequence specific given that replacing the a IIb CT with an a 5 CT rendered a IIb b 3 constitutively active despite a IIb and a 5 having a very similar CT MP region (O'Toole et al., 1991) . Furthermore, replacing the a IIb CT MD region with a penta-alanine sequence reduces the interaction of isolated a IIb and b 3 TM-CT peptides (Li et al., 2014) . Second, the C-terminal a IIb CT MD region is unique with seven acidic amino acids (supplementary material Fig. S1 ) that have been shown to interact with the Nterminal a IIb CT MP region in a NMR structure of membraneanchored a IIb CT peptide (Vinogradova et al., 2000) . This interaction might be important in keeping the resting integrin state, but the same interaction was not found in the NMR structure of the a IIb b 3 TM-CT heterodimer determined in organic solvent (Yang et al., 2009) (Fig. 1C) . Another possible mechanism of aintegrin CT MD region contributing to the inactive state is through its interaction with the negative integrin regulators. Most of the negative regulators identified so far bind to the conserved aintegrin CT MP region (Pouwels et al., 2012; Bouvard et al., 2013; Morse et al., 2014) , but the MD region might also contribute to the interaction to some extent, which helps maintain the resting integrin state.
It has been shown that membrane-permeant peptides containing the a IIb CT MD sequences specifically blocked a IIb b 3 activation in platelets (Ginsberg et al., 2001; Koloka et al., 2008) . A recent study has suggested that this is because the exogenous a IIb CT MD peptides inhibit the association of talin with a IIb b 3 in thrombin-stimulated platelets (Gkourogianni et al., 2013) . However, this is unlikely owing to competition with or steric hindrance of the talin-binding sites of b 3 CT given that deletion of the a IIb CT MD region did not increase the binding of talin-1 head to b 3 CT ( Fig. 8C and Li et al., 2014) . Talin activates integrin by disrupting the TM and CT domain association, whereas the a IIb CT MD region negatively regulates this process by enhancing the structural stability of the a IIb b 3 TM-CT heterodimer.
In addition to the negative regulation of a CT MD region in integrin activation, our data demonstrate a positive role for the aintegrin CT MD region in talin-induced integrin activation. Displacement of a-integrin CT MD region by the b CT-bound talin-1 head domain might destabilize the integrin TM-CT dimerization, leading to integrin activation. The potential steric clashes between the talin-1 head and a IIb CT MD residues based on structure superposition have been proposed to play a role in this process (Yang et al., 2009; Zhu et al., 2009; Ye et al., 2011 ). This hypothesis was tested recently by replacing the a IIb CT MD region with a penta-alanine peptide or the CT MD sequence of a 5 or a L integrin (Li et al., 2014) . It has been shown that the a IIb chimeras remain responsive to talin-1-head-induced activation. Based on this result, it has been concluded that the a IIb CT MD region participates in integrin activation through steric clashing with the talin-1 head without the requirement of a specific sequence. We examined the potential role of steric clashes using the truncated a IIb constructs that retain the first two residues of a IIb CT MD region (i.e. NR997Tr) given that the structural superposition showed major steric clashes between these residues and the talin-1 head (supplementary material Fig. S4B) . The steric clash model is not consistent with the results showing that the bulky YY997 mutations significantly reduced, rather than enhancing, the talin-mediated a IIb b 3 activation. It should be noted that both the length and sequence of the a IIb CT MD region are important to maintain the resting integrin state. Indeed, truncating the a IIb CT or swapping the a IIb CT MD region with other amino acids renders a IIb b 3 more active than WT integrin as shown in our study and by Li et al. (Li et al., 2014) . In addition, the conformational flexibility of both the a IIb and b 3 CT MD region (Zhu et al., 2009; Metcalf et al., 2010) would eliminate clashes in a talin-a IIb b 3 complex. Thus, the steric clash model is not the sole mechanism through which the a IIb CT MD region participates in talin-induced integrin activation.
An interaction between a IIb CT and talin has been reported (Knezevic et al., 1996; Yuan et al., 2006; Gingras et al., 2009; Raab et al., 2010) . Although it might not have a major contribution to a IIb b 3 and talin interaction, a transient and weak interaction between a IIb CT and talin might stabilize the active conformation of a IIb CT during integrin activation. Recent biochemical and molecular dynamic simulation studies indicate that the a IIb CT increases its membrane embedding upon integrin inside-out activation (Kurtz et al., 2012; Provasi et al., 2014) . The a IIb -YY997 mutation might affect the membrane embedding of a IIb TM-CT and reduces integrin activation since tyrosine residues tend to locate at the membrane boundary (Killian and von Heijne, 2000) . A cluster of negatively charged residues at the a IIb CT MD region may disfavor the negatively charged cell membrane and inhibit the membrane embedding of a IIb TM-CT, while an interaction between the talin-head and the a IIb CT MD acidic residues as indicated by a molecular dynamic simulation study (Provasi et al., 2014) might facilitate the membrane embedding of a IIb TM-CT to activate integrin. In addition, the capability of talin to activate integrin depends on its binding to both b-integrin CT and cell membrane (Wegener et al., 2007; Anthis et al., 2009; Moore et al., 2012; Song et al., 2012; Kalli et al., 2013) . The interaction between a CT and talin might help talin maintain a proper orientation for the favorable interaction with b-integrin CT and cell membrane in order to stabilize the active conformation of TM-CT (supplementary material Fig.  S4C ). Considering the significant diversity of the a-integrin CT MD region, it is tempting to propose that this diversity might regulate integrin inside-out activation in an a-integrin-specific manner as it has been suggested that the a-integrin CT MD regions determine the specificity of integrin outside-in signaling (Chan et al., 1992; Shaw et al., 1995; Sastry et al., 1999; Na et al., 2003; Goel et al., 2014) .
Another potential mechanism of regulating integrin activation by a-integrin CT is through its interacting proteins. Interestingly, most a-integrin-CT-binding proteins identified so far interact with the conserved membrane-proximal GFFKR motif and function as inhibitors of integrin activation (Pouwels et (n §3). *P,0.05; **P,0.01; ***P,0.001; ns, not significant (unpaired twotailed t-tests were used for the comparison with mC control group).
mechanism of their negative regulation is not well-defined. A Rap1 effector, RapL, has been shown to activate a L b 2 integrin through binding to the a L CT MD sequence proximal to the GFFKR motif (Katagiri et al., 2003) . It is not known how RapL cooperates with talin and/or kindlin to activate a L b 2 integrin. The requirement of a-integrin CT MD region for integrin activation suggests that as-yet undiscovered regulatory proteins that interact with a-integrin CT MD region are involved in integrin activation, probably in an integrin-specific manner. It has been shown that deletion of the a IIb CT MD region did not affect a IIb b 3 -mediated cell adhesion and spreading, but led to aberrant recruitment of a IIb b 3 into focal adhesions formed by other integrins (Ylänne et al., 1993) . The underlined mechanism is not known. The same phenomenon was observed with a 2 integrin . However, deletion of the a CT MD region of a 1 , a 2 , a 4 , a V or a 6 integrin diminished cell adhesion (Kassner and Hemler, 1993; Kawaguchi and Hemler, 1993; Shaw and Mercurio, 1993; Filardo and Cheresh, 1994; Kassner et al., 1994; Kawaguchi et al., 1994; Yauch et al., 1997; Abair et al., 2008) , indicating that there are different regulatory roles of a CT MD regions among different integrins.
Our data on the b 3 -K716A mutation have important implications for the current model of integrin inside-out activation. It has been suggested that the b 3 -K716 residue helps to maintain a proper tilt angle for the b 3 TM domain in the resting state by placing its basic side chain near negatively charged phospholipid head groups (Kim et al., 2011a) . It has been proposed that the b 3 -K716A mutation or talin binding to b 3 CT induces integrin activation by changing the tilt angle of b 3 TM domain to disturb the a IIb b 3 TM-CT interaction.
It has also been shown that the tilt angle change of b 3 TM domain can occur upon adding the talin-1 head to the isolated b 3 TM-CT peptide embedded in lipid nanodiscs in the absence of a IIb TM-CT peptide (Kim et al., 2012) . We found that complete deletion of a IIb CT MD region greatly enhanced the activation of b 3 -K716A. If the talin-1 head could induce integrin activation by changing the tilt angle of the b 3 TM domain as b 3 -K716A does, which seems to be independent of a IIb CT according to the data by Kim et al. (Kim et al., 2012) we would expect to see an enhanced activation mediated by the talin-1 head in the absence of the a IIb CT MD region. However, an opposite result was obtained. The talin-1 head failed to activate integrin when the a-integrin CT MD region was completely deleted. By using a cysteine-scanning accessibility method with intact integrin on the cell surface, another group has suggested that b 3 -K716 is embedded in the lipid bilayer both in the inactive and active conformation. They detected conformational change of the a IIb TM-CT but not the b 3 TM-CT domain in activating integrin mutants (Kurtz et al., 2012) . Our structural study revealed that interactions between the b 3 -K716 side chain and the a IIb F992 and K994 backbone carbonyl oxygens are important in maintaining the resting integrin state (Zhu et al., 2009) . These interactions were observed in a molecular dynamic simulation study starting with the NMR structure of a IIb b 3 TM-CT determined in lipid bicelles (Provasi et al., 2014) . The direct interaction between b 3 -K716 and a IIb CT was also observed in a NMR study (Metcalf et al., 2010) . Clearly, further investigations are required to reconcile these discrepancies.
It has been proposed that the conserved a IIb -R995 and b 3 -D723 form a salt bridge that restrains a IIb b 3 in the resting state (Hughes et al., 1996) . One of the current models suggests that talin-1 head binding to the b 3 CT breaks the putative salt-bridge to induce integrin activation (Anthis et al., 2009; Anthis and Campbell, 2011) . Despite the very disruptive effect of a IIb -R995 and b 3 -D723 mutations on a IIb b 3 TM dimerization observed using isolated TM-CT peptides Lau et al., 2009) , their mutations only moderately activated full-length integrins (Peyruchaud et al., 1998; Ma et al., 2006; Ghevaert et al., 2008; Zhu et al., 2009) . Remarkably, we found that the a IIb -K993Tr and a IIb -K994Tr mutation, in which the a IIb -R995 was deleted, abolished rather than synergized integrin activation induced by the b 3 -D723 mutations and/or by the talin-1 head. In sharp contrast, it was only in the presence of a IIb CT MD region that the a IIb -R995 or b 3 -D723 mutations greatly synergized a IIb b 3 activation and the conformational change induced by the talin-1 head. Thus, although a IIb -R995 and b 3 -D723 are involved in integrin activation, they might not be central in structurally maintaining integrin in the resting state. Mutagenesis data has suggested that the extracellular domains are also involved in stabilizing the a IIb b 3 TM dimer as well as their membrane embedding Kurtz et al., 2012) . Caution should be taken when interpreting data obtained using isolated TM-CT peptides.
Natural mutations of a IIb -R995 and b 3 -D723 (a IIb -R995Q or a IIb -R995W and b 3 -D723H) have been identified in patients with thrombocytopenia (a relative decrease of platelets in blood) (Peyruchaud et al., 1998; Ghevaert et al., 2008; Kunishima et al., 2011) . Although it was not studied in these patients, our data here suggest that a IIb b 3 integrin with a IIb -R995 or b 3 -D723 mutations might be more responsive to agonist stimulation leading to more platelet aggregation than in wild type, which might simultaneously cause a reduction in the amount of platelets in blood. An equivalent Arg to Ala mutation of a 4 integrin CT has been found to aberrantly activate a 4 integrin in genetic knock-in mice (Imai et al., 2008) . We also found that the equivalent b 2 -D709A mutation renders a L b 2 integrin hyper-responsive to talin-1-head-induced activation. Interestingly, an equivalent Asp to Ala mutation in b 1 integrin CT did not result in obvious defect in vivo (Czuchra et al., 2006) , despite the fact that the b 1 subunit forms heterodimers with 12 a-integrin subunits. Thus, the conserved aArg and b-Asp of the integrin CT might play different roles in regulating integrin activation among different integrins.
Among the caveats of our study is that the effect of a IIb CT MD mutations on talin-1-head-mediated integrin activation was much more dramatic with the b 3 -D723A mutant compared with WT b 3 . It should be noted that overexpression of talin-1 head only moderately activates WT integrin. Increasing the DNA amount for transfection did not further increase integrin activation (data not shown). It is possible that overexpression of talin-1 head alone might not be sufficient to induce maximal integrin activation given that the overexpressed talin-1 head is not specifically recruited to the integrin CT and only a small population of integrins encounter the talin-1 head probably by chance. In the physiological situation, the active full-length talin might apply traction force to its bound bintegrin CT through the coupled actin cytoskeleton (Zhu et al., 2008; Schürpf and Springer, 2011) , and thus exert a more disruptive effect on the integrin TM-CT interaction than that mediated by the talin head alone. The b 3 -D723A mutation or other activating mutations like a IIb -R995A and b 3 -G135A might facilitate talin-head-induced integrin activation by decreasing the energy barrier. The b 3 -D723A mutation significantly increases talin-1-head-induced integrin activation by more than 20-fold compared with WT. Moreover, PMA stimulates a significant increase in soluble ligand binding to the a IIb -b 3 -D723A mutant but not to the WT in K562 cells in suspension. Consistent with the soluble ligand-binding assay, the b 3 -D723A or a IIb -R995A mutation significantly enhanced talin-1-head-induced integrin conformational change. Thus, the combination of b 3 -D723A and the a IIb CT MD mutations greatly improves the sensitivity of our assay. Similarly, the combination of the b 3 activating mutations and the a IIb CT MD truncations enabled us to reveal the contribution of a IIb CT MD region to maintaining the resting state.
Talin-1-head-induced integrin extension, but not headpiece opening, has been directly visualized by EM using the purified intact a IIb b 3 embedded in the lipid nanodiscs (Ye et al., 2010) . We have recently shown that the talin-1-head-induced integrin conformational change needs to be propagated to the ligandbinding site, probably through headpiece opening, in order to activate integrin (Zhang et al., 2013) . In this study, by using the conformation-dependent mAbs that report integrin extension (319.4 for b 3 and 370.3 for a IIb ; KIM127 for b 2 ) and headpiece opening (M24 for b 2 ), we further demonstrated that the talin-1 head induced extension and headpiece opening of integrin. In particular, we detected enhanced integrin conformation change (extension and headpiece opening) when the talin-1 head was co-expressed with kindlins. Kindlin-2 or -3 exerted more effect on M24 binding than did KIM127 binding to a L b 2 . This is consistent with a recent study showing that both talin-1 and kindlin-3 were required for inducing the extended open headpiece conformation of a L b 2 (Lefort et al., 2012) . Remarkably, the talin-1-head-and kindlin-induced integrin extension and headpiece opening require the presence of an aintegrin CT MD region. However, because how kindlins induce integrin activation remains unknown, the requirement of an aintegrin CT MD region for kindlin-mediated integrin activation can only be interpreted as a secondary effect due to the loss of effectiveness of talin according to the current data.
We found that the talin-1-head-and kindlin-induced binding of b 3 LIBS mAb 319.4 is not completely abolished in the absence of the a IIb CT MD region. This is in contrast with the binding of a IIb LIBS mAb 370.3. This indicates that the talin-1 head might exert some extent of conformational change on the b 3 subunit even in the absence a IIb CT MD region, but that a fully active integrin conformation induced by talin and kindlin requires the involvement of the a IIb CT MD region. In summary, our study provides new insights into integrin inside-out activation and suggests that further structural studies are required to understand the precise mechanism by which the a-integrin CT MD region is involved in talin-and kindlin-mediated integrin activation.
MATERIALS AND METHODS

DNA constructs
DNA constructs of human a IIb b 3 , a V b 3 , a L b 2 , and the EGFP-tagged mouse talin-1 head (EGFP-TH) were as described previously (Zhu et al., 2007; Bouaouina et al., 2008; Zhang et al., 2013) . Human kindlin-2 or kindlin-3 was cloned into the pmCherry-C1 vector (Clontech). Mutations were introduced by site-directed mutagenesis with the QuikChange kit (Agilent Technologies).
Antibodies and ligands
PAC-1 (BD Biosciences) is a ligand-mimetic mAb (IgM) specific for activated a IIb b 3 integrin (Shattil et al., 1985) . AP3 is a conformationindependent anti-b 3 mAb (Kouns et al., 1991) . 319.4 is a LIBS mAb that binds to the b 3 I-EGF domains (Zhang et al., 2013) . 370.3 is a LIBS mAb that binds to the a IIb calf-1 domain (Zhang et al., 2013) . PE-labeled TS2/ 4 (BioLegend) is a non-functional anti-a L mAb (Sanchez-Madrid et al., 1982) . KIM127 (which binds to I-EGF-2 domain) and mAb 24 (M24, which binds to bI domain) are anti-b 2 LIBS mAbs (Dransfield and Hogg, 1989 Human Fn9-10 was as described previously (Takagi et al., 2001) . Human fibronectin and ICAM-1 (with a C-terminal human IgG1 Fc tag, ICAM-1-Fc) were purchased from Sigma-Aldrich and Sino-Biological, respectively.
Soluble ligand binding assay by flow cytometry with 293FT transfectants PAC-1 binding of 293FT (Life Technologies) cells transfected with a IIb b 3 only were as described previously (Zhang et al., 2013) . For the talin-1-head-induced ligand binding assay, 293FT cells were cotransfected with integrin constructs and EGFP or EGFP-TH for at least 24 hours. For kindlin-induced ligand binding, 293FT cells were cotransfected with integrin constructs plus EGFP-TH and mCherry or mCherry-kindlin for at least 24 hours. Ligand binding was performed in HBSGB buffer (20 mM HEPES pH 7.4, 150 mM NaCl, 5.5 mM glucose, and 1% BSA) plus 5 mM EDTA or 1 mM Ca 2+ and 1 mM Mg 2+ (Ca/Mg) at 25˚C for 30 min with 5 mg/ml PAC-1 for a IIb b 3 , 20 mg/ml each of ICAM-1-Fc and biotin-labeled mouse anti-human IgG1 Fc for a L b 2, or 50 mg/ml Alexa-Fluor-647-labeled Fn9-10 or Fn for a V b 3 . Cells were then washed and incubated in Ca/Mg on ice with the detecting reagents: 10 mg/ml each of biotinylated AP3, PE-labeled streptavidin and AlexaFluor-647-labeled goat anti-mouse IgM for a IIb b 3 , biotinylated AP3 and PE-labeled streptavidin for a V b 3 , PE-labeled TS2/4, and Alexa Fluor 647-labeled streptavidin for a L b 2 . Integrin and EGFP double-, or integrin, EGFP, and mCherry triple-positive cells were acquired for calculating mean fluorescence intensity (MFI) by flow cytometry. Ligand binding was presented as the normalized MFI, that is ligand MFI (after subtracting the ligand the MFI in EDTA) as a percentage of integrin MFI.
PMA-induced integrin ligand binding in K562 cells
Human K562 cells were transfected with a IIb b 3 constructs by Lipofectamine 2000 (Life Technologies). Cells were incubated in RPMI-1640 medium plus 1% BSA with PMA for 10 minutes followed by a 10-minute incubation with PAC-1. Cells were then washed and incubated with Alexa-Fluor-488-labeled AP3 and Alexa-Fluor-647-labeled goat anti-mouse IgM on ice for 30 minutes. Integrin-positive cells were acquired for calculating MFI by flow cytometry. Ligand binding was presented as the MFI normalized by integrin expression.
LIBS epitope exposure
Talin-1-head-and kindlin-induced LIBS epitope exposure was as described previously (Zhang et al., 2013) . In brief, 293FT transfectants were first incubated with or without (as background) the biotinylated LIBS mAb in Ca/Mg at 25˚C for 30 mins, and then washed and incubated with the detecting reagents: Alexa-Fluor-647-labeled AP3 and PElabeled streptavidin for a IIb b 3 , PE-labeled TS2/4 and Alexa-Fluor-647-labeled streptavidin for a L b 2 . Integrin and EGFP double-, or integrin, EGFP and mCherry triple-positive cells were analyzed for calculating the MFI. LIBS mAb binding is presented as MFI normalized to the integrin expression, that is the LIBS mAb MFI (after subtracting the background MFI) as a percentage of the integrin MFI.
Disulfide crosslinking and immunoprecipitation
Metabolic labeling with [ 35 S]cysteine/methionine and disulfide crosslinking using intact cells of 293FT transfectants were as described previously (Zhu et al., 2009 ). Formation of disulfide bonds was induced by treating the cells with CuSO 4 and o-phenanthroline on ice. Integrins were immunoprecipitated with anti-a IIb mAb 10E5 from the cell lysate and subjected to nonreducing SDS-PAGE and autoradiography. For the talin-1-head-binding assay, a IIb b 3 integrins were immunoprecipitated with mAb 10E5 from cells co-transfected with EGFP or EGFP-TH. Binding of the talin-1 head was detected by western blotting with rabbit anti-EGFP polyclonal antibody (Origene). b 3 integrin was detected with rabbit anti-b 3 H-96 (Santa Cruz Biotechnology).
